205 related articles for article (PubMed ID: 16273495)
1. [Pain treatment of patients with incurable malignant tumors].
Schwarzer A; Klaschik E; Nauck F
Dtsch Med Wochenschr; 2005 Nov; 130(45):2561-5. PubMed ID: 16273495
[TBL] [Abstract][Full Text] [Related]
2. [Pain therapy in palliative medicine].
Klaschik E; Nauck F; Krieg R
Fortschr Med; 1998 May; 116(15):22-4, 26-8, 30. PubMed ID: 9648385
[TBL] [Abstract][Full Text] [Related]
3. Pain management of opioid-treated cancer patients in hospital settings in Denmark.
Lundorff L; Peuckmann V; Sjøgren P
Acta Anaesthesiol Scand; 2008 Jan; 52(1):137-42. PubMed ID: 18005379
[TBL] [Abstract][Full Text] [Related]
4. Pain and pain alleviation in hospital-based home care: demographic, biological and treatment factors.
Heedman PA; Strang P
Support Care Cancer; 2003 Jan; 11(1):35-40. PubMed ID: 12527952
[TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
6. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
8. [Pain therapy in patients with incurable tumors of the head and neck].
Luckhaupt H
HNO; 1989 Nov; 37(11):465-8. PubMed ID: 2479622
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
[TBL] [Abstract][Full Text] [Related]
10. Clinical and financial analysis of an acute palliative care unit in an oncological department.
Mercadante S; Intravaia G; Villari P; Ferrera P; David F; Casuccio A; Mangione S
Palliat Med; 2008 Sep; 22(6):760-7. PubMed ID: 18715976
[TBL] [Abstract][Full Text] [Related]
11. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
Clemens KE; Klaschik E
Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
[TBL] [Abstract][Full Text] [Related]
12. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.
Patanwala AE; Jarzyna DL; Miller MD; Erstad BL
Pharmacotherapy; 2008 Dec; 28(12):1453-60. PubMed ID: 19025426
[TBL] [Abstract][Full Text] [Related]
13. Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?
Mercadante S; Villari P; Ferrera P; Casuccio A
Eur J Pain; 2006 Feb; 10(2):153-9. PubMed ID: 16310719
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
15. Patterns of pain experiences and use of analgesics among hospitalized cancer patients in Korea.
Lee EO; Suh SR; Kim JY
Nurs Clin North Am; 1995 Dec; 30(4):647-57. PubMed ID: 7501533
[TBL] [Abstract][Full Text] [Related]
16. [Pain therapy in tumor patients and in palliative medicine. 1: Drug therapy].
Ensink FB; Bautz MT; Hirn AM; Nass S; Kettler D; Hanekop GG
Zentralbl Chir; 1998; 123(6):649-63. PubMed ID: 9703640
[TBL] [Abstract][Full Text] [Related]
17. [Pain therapy in patients with gynecologic tumors. Analysis of ambulatory pain management].
Gralow I; von Hornstein W; Behling H
Zentralbl Gynakol; 1991; 113(23):1288-97. PubMed ID: 1724588
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects and treatment of pain in children and adolescents with cancer.
Monteiro Caran EM; Dias CG; Seber A; Petrilli AS
Pediatr Blood Cancer; 2005 Dec; 45(7):925-32. PubMed ID: 16106427
[TBL] [Abstract][Full Text] [Related]
19. Outcome of opioid switching 4 weeks after discharge from a palliative care unit.
Mercadante S; Ferrera P; Casuccio A
Curr Med Res Opin; 2011 Dec; 27(12):2357-60. PubMed ID: 22029619
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]